2026 NPPES data Ophthalmic Plastic and Reconstructive Surgery Physician NPI 1225037120 MD
Verify on CMS →

Sherif Khalil, MD

Ophthalmic Plastic and Reconstructive Surgery Physician in Houston, Texas.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 290 in Ophthalmic Plastic and Reconstructive Surgery Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 544 beneficiaries · Ophthalmic Plastic and Reconstructive Surgery Physician avg: 624
Generic prescribing
51%
generic claims · 49% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
93.4/100
▲ 10 pts above national avg 83.1 · Exceptional
Industry payments
$340.74
14 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Sherif Khalil, MD reported a CMS MIPS final score of 93.4/100 - above the 83.1 national average - and filed 2,297 Medicare Part D claims in 2023.

93.4/100
MIPS score · +10 vs avg
2K
Part D claims, 2023
51%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Sherif Khalil, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure

93 Top 29% higher than 71% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90+: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Sherif Khalil, MD sits

This provider among ophthalmic plastic and reconstructive surgery physician peers

Across the 141 ophthalmic plastic and reconstructive surgery physician providers who report both Medicare Part D prescribing and a MIPS quality score, Sherif Khalil, MD writes more Part D claims than 95% of them and scores higher on MIPS quality than 70% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.949.974.899.8Part D claim volume, percentile in specialtyMIPS quality, percentilePart D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 48Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 55Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 75Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 13Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 23Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 5Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 52Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 80Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 13Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 68Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 40Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 23Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 95Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 3Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 93Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 95Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 95Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 8Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 47Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 95Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 32Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 42Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 10Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 70Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 85Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 45Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 77Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 57Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 20Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 87Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 50Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 72Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 82Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 33Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 2Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 58Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 35Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 90Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 38Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 37Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 13Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 23Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 0Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 7Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 23Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 18Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 87Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 60Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 83Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 53Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 23Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 73Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 43Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 22Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 62Sherif Khalil, MD-Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 70
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one ophthalmic plastic and reconstructive surgery physician peer from a representative sample of 60; the gold marker is Sherif Khalil, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Sherif Khalil, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Sherif Khalil, MD?

High performer (top quartile)

NPI registry status

Active

Issued 07/21/2005

NPI 1225037120

Primary specialty

Ophthalmic Plastic and Reconstructive Surgery Physician

Rare

290 US NPIs in this specialty

Medicare Part D claims

2,297 268% vs specialty avg

2023 prescription claims

Specialty avg: 624

MIPS final score

93.4/100 10.3 pts vs avg

Exceptional band

vs 83.1 national avg

Specialty distribution in Texas

How Ophthalmic Plastic and Reconstructive Surgery Physician compares to other specialties among Texas providers

Texas providers
Behavior Technician - 5.6%Behavior Technician5.6%Student in an Organized Health Care Education/Training Program - 5.1%Student in an Organized Health Care Education/Training Program5.1%Family Nurse Practitioner - 4.5%Family Nurse Practitioner4.5%Professional Counselor - 4.4%Professional Counselor4.4%Pharmacist - 4.4%Pharmacist4.4%Speech-Language Pathologist - 3.9%Speech-Language Pathologist3.9%Ophthalmic Plastic and Reconstructive Surgery Physician - 0%Ophthalmic Plastic and Reconstructive Surgery Physician0%
Largest specialties in Texas (% of in-state providers)

Medicare quality performance, MIPS

Sherif Khalil, MD's 2023 MIPS final score plotted against the Ophthalmic Plastic and Reconstructive Surgery Physician national average

High performer (top quartile)
MIPS Final Score
93.4/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmic Plastic and Reconstructive Surgery Physician) - 93.4/100 vs national avg 83.1

0%100%National avg83%93.4%
MIPS final score (Ophthalmic Plastic and Reconstructive Surgery Physician) - 93.4/100 vs national avg 83.1
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Sherif Khalil, MD appears in the CMS NPPES registry as an Ophthalmic Plastic and Reconstructive Surgery Physician provider holding MD credentials at 915 GESSNER RD, Houston, TX, 77024, with a listed phone of (713) 467-6474. NPI 1225037120 was issued on 07/21/2005.

Medicare Part D records for calendar year 2023 show 2,297 prescription claims written by this provider, covering 544 Medicare beneficiaries and totaling roughly $338K in drug spend, split 49% brand-name and 51% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.4/100 for the 2023 performance year (Quality 98.1, Cost 81.5), compared with the national average of 83.1.

Ophthalmic Plastic and Reconstructive Surgery Physician is a narrow specialty nationwide, with 290 enrolled providers across 46 states and an average of 624 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

915 GESSNER RD
Houston, TX 77024

Provider Details

NPI 1225037120
Specialty Ophthalmic Plastic and Reconstructive Surgery Physician
Credentials MD
Gender Male
NPI Issued 07/21/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

93.4221
Final Score
Avg: 83.1
98.1464
Quality
81.472
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where Sherif Khalil, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Hea Clinic PA
Houston, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Sherif Khalil, MD. Source: openpaymentsdata.cms.gov.

Total received

$341

Largest payer

Bausch & Lomb Americas Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Texas TMB 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Sherif Khalil, MD. To verify Sherif Khalil, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Sherif Khalil, MD - brand share 49.0%
Ophthalmic Plastic and Reconstructive Surgery Physician average

49% brand-name claims vs 51% generic, on 2,297 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,297
Total Claims
$338K
Total Drug Cost
544
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,564
Total Day Supply
131,279
Brand vs Generic
49% brand / 51% generic
Brand Drug Cost
$283K
Generic Drug Cost
$55K

Patient Demographics

Average Patient Age
77.6 years
Avg HCC Risk Score
1.18
Gender Split
61% female / 39% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Sherif Khalil, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
1,152
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
319
Lumigan
Bimatoprost
166
Prednisolone Acetate
66
Restasis
Cyclosporine
57
Brimonidine Tartrate
52
Timolol Maleate
50
Travoprost
50
Erythromycin
Erythromycin Base
47
Vyzulta
Latanoprostene Bunod
32

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmic Plastic and Reconstructive Surgery Physician Overview

How Sherif Khalil, MD fits within the Ophthalmic Plastic and Reconstructive Surgery Physician landscape nationally.

290
Ophthalmic Plastic and Reconstructive Surgery Physician Providers in US
46
States with Ophthalmic Plastic and Reconstructive Surgery Physician
624
Avg Claims per Provider

Sherif Khalil, MD's 2,297 claims are above the specialty average of 624.

Nearby Ophthalmic Plastic and Reconstructive Surgery Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Khalil.

Compare Ophthalmic Plastic and Reconstructive Surgery Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Ophthalmic Plastic and Reconstructive Surgery Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Sherif Khalil, MD's specialty?
Sherif Khalil, MD specializes in Ophthalmic Plastic and Reconstructive Surgery Physician and practices in Houston, Texas. Credentials: MD.
How much does Sherif Khalil, MD prescribe under Medicare Part D?
In 2023, Sherif Khalil, MD wrote 2,297 Medicare Part D claims totaling $338K in drug costs for 544 beneficiaries.
What is Sherif Khalil, MD's Medicare quality score?
Sherif Khalil, MD has a CMS MIPS Final Score of 93.4/100 (Quality: 98.1, Cost: 81.5). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Sherif Khalil, MD located?
Sherif Khalil, MD is located at 915 GESSNER RD, Houston, TX, 77024. Phone: (713) 467-6474.
What is Sherif Khalil, MD's NPI number?
Sherif Khalil, MD's National Provider Identifier (NPI) is 1225037120, issued on 07/21/2005.
Does Sherif Khalil, MD prescribe more brand-name or generic drugs?
Sherif Khalil, MD's prescribing is 49% brand-name and 51% generic drugs by claim count, with $283K in brand drug costs.
How many Ophthalmic Plastic and Reconstructive Surgery Physician providers are there in the US?
There are 290 Ophthalmic Plastic and Reconstructive Surgery Physician providers across 46 states in the US. The average Ophthalmic Plastic and Reconstructive Surgery Physician provider writes 624 Medicare Part D claims per year.
What drugs does Sherif Khalil, MD prescribe most often?
Based on 2023 Medicare Part D data, Sherif Khalil, MD's most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Lumigan. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Sherif Khalil, MD accept Medicare?
Sherif Khalil, MD appears in CMS Medicare data with 2,297 Part D claims and 544 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Sherif Khalil, MD's credentials?
Sherif Khalil, MD's NPI is 1225037120 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.